ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,115Medicare Part D Prescriptions Filled, Including Refills

Rank: 82 out of 2680

$1.34M Total Retail Price of All Prescriptions

Rank: 22 out of 2680

251 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 251 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 251 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 11,640 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

55% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$102 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

52 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
CRESTOR 741 687 1 15
CARVEDILOL 442 395 2 27
NEXIUM 441 400 3 19
AMLODIPINE BESYLATE 379 361 4 3
LOVAZA 298 260 5 47
ZOLPIDEM TARTRATE 293 259 6 17
METOPROLOL TARTRATE 282 267 7 8
ZETIA 238 226 8 69
SIMVASTATIN 225 195 9 1
TAMSULOSIN HCL 223 219 10 25
ALENDRONATE SODIUM 223 194 10 20
PLAVIX 215 209 12 41
DIOVAN HCT 188 184 13 54
ATORVASTATIN CALCIUM 183 154 14 10
DEXILANT 179 165 15 133
FUROSEMIDE 177 152 16 7
METOPROLOL SUCCINATE 174 174 17 11
CLOPIDOGREL 173 163 18 30
LIPITOR 152 152 19 78
METFORMIN HCL 148 144 20 6
ADVAIR DISKUS 147 117 21 32
OMEPRAZOLE 142 97 22 2
DIOVAN 142 132 22 26
ATENOLOL 138 127 24 14
LOSARTAN-HYDROCHLOROTHIAZIDE 135 105 25 46
JANUMET 133 114 26 83
MICARDIS HCT 133 128 26 205
RAMIPRIL 131 120 28 49
BENICAR HCT 130 111 29 125
LIDODERM 129 125 30 74
CREON 128 109 31 112
LEVOTHYROXINE SODIUM 124 121 32 4
HYDROCHLOROTHIAZIDE 113 80 33 9
SINGULAIR 112 104 34 64
MECLIZINE HCL 112 102 34 105
LISINOPRIL 108 88 36 5
FLUTICASONE PROPIONATE 108 84 36 38
CELEBREX 108 102 36 75
JANUVIA 107 107 39 34
SYNTHROID 104 82 40 39
GLIMEPIRIDE 99 81 41 51
MELOXICAM 96 76 42 50
TRILIPIX 94 81 43 151
AVODART 94 94 43 165
HYDRALAZINE HCL 91 74 45 99
DONEPEZIL HCL 91 74 45 28
NAMENDA 90 80 47 43
ENALAPRIL MALEATE 88 87 48 24
RANEXA 87 87 49 173
CLONIDINE HCL 85 85 50 84
IBUPROFEN 84 68 51 63
VOLTAREN 81 73 52 103
AZITHROMYCIN 75 65 53 40
SPIRIVA 73 57 54 36
SOLARAZE 68 68 55 172
AMITIZA 68 48 55 190
DICYCLOMINE HCL 66 61 57 267
PRADAXA 64 64 58 203
ESCITALOPRAM OXALATE 64 46 58 82
POTASSIUM CHLORIDE 62 40 60 29
SPIRONOLACTONE 62 48 60 86
ZOVIRAX 61 57 62 301
ACTONEL 60 60 63 197
AMLODIPINE BESYLATE-BENAZEPRIL 57 57 64 58
ISOSORBIDE MONONITRATE ER 54 54 65 57
IBANDRONATE SODIUM 54 54 65 223
ACETAMINOPHEN-CODEINE 52 42 S3 67 156
MICARDIS 52 52 67 219
PROAIR HFA 52 43 67 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.